Uncategorized

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, will be presenting at the Clinical Research Governance World Conference & International Clinical Trial Center Network Symposium 2023 in Hong Kong this month.

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024 Read More »

GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23

GE HealthCare will highlight more than 40 innovations, including several key artificial intelligence -enabled technologies within the Imaging, Ultrasound, and digital space at the Radiological Society of North America’s 2023 Annual Meeting taking place Nov. 26-30 in Chicago, IL.

GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23 Read More »

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, has published positive results from a human clinical trial involving its potentially game-changing technology that enables vaccines to be applied to the skin using a small patch, instead of using traditional needle and syringe.

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa Read More »

Scroll to Top